# Ningju Biological

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ningju-biological

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Latest round: Series A (Sep 20, 2024)
- Investors on record: 1

## About

Established in 2022 and based in Shenzhen, China, Ningju Biological is a medical materials developer that provides hemostatic sealing and repair materials. In September 2024, Ningju Biological raised a series A funding from Triwise Capital.

The company's main products are hemostatic sealing materials and repair materials, which can be used in bleeding and injury situations.

The company generates revenue by providing biomedical materials such as repair materials.

The company will use the series A funding to develop hemostatic sealing and repair materials, and expand the market.

## Funding rounds

- Series A, Sep 20, 2024 — Triwise Capital

## Investors

- Triwise Capital (https://capitalatlas.ai/funds/triwise-capital) — Series A